# REPLIGEN CORP (RGEN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from REPLIGEN CORP's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/RGEN/mda/fy2025/): filed 2026-02-26; accession 0001193125-26-076528 (https://www.sec.gov/Archives/edgar/data/730272/000119312526076528/rgen-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/RGEN/mda/fy2024/): filed 2025-03-14; accession 0000950170-25-038999 (https://www.sec.gov/Archives/edgar/data/730272/000095017025038999/rgen-20241231.htm)
- [FY 2023 MD&A](/company/RGEN/mda/fy2023/): filed 2024-02-22; accession 0000950170-24-018809 (https://www.sec.gov/Archives/edgar/data/730272/000095017024018809/rgen-20231231.htm)
- [FY 2022 MD&A](/company/RGEN/mda/fy2022/): filed 2023-02-22; accession 0000950170-23-003793 (https://www.sec.gov/Archives/edgar/data/730272/000095017023003793/rgen-20221231.htm)
- [FY 2021 MD&A](/company/RGEN/mda/fy2021/): filed 2022-02-17; accession 0000950170-22-001430 (https://www.sec.gov/Archives/edgar/data/730272/000095017022001430/rgen-20211231.htm)

Back to /company/RGEN/